Latest news with #SiemensHealthineers
Yahoo
an hour ago
- Business
- Yahoo
Market to Surpass $250 Billion by 2030, Driven by Virtual Consultations, Government Investment, and Emerging AI- and IoT-Powered Care Platforms
The telemedicine technologies market report offers in-depth analysis, trends, and forecasts through 2030. It covers major players, innovations, and geographic opportunities. Key insights include market dynamics, patient subscription software, and virtual consultations. The report details regulatory assessments, emerging technologies, and market rankings. Regional segments and major country analyses are included, with estimates providing revenue data from 2022-2030 and insights into sustainability trends, ESG developments, and patent grants. Major companies profiled include Siemens Healthineers and Teladoc Health. Global Telemedicine Technologies Market Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Global Markets for Telemedicine Technologies" report has been added to global market for telemedicine technologies is projected to grow from $146.9 billion in 2025 to $251.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2030. This report provides an analysis of the telemedicine technologies market, including market estimations and trends through 2030. It examines major players, competitive insights, innovations, advertising flow, geographic opportunities and territorial openings. The report addresses major players' acquisitions, collaborations, partnerships and item portfolios. It covers drivers, restraints, opportunities, emerging technologies and a regulatory scenario assessment. The report also includes market projections through 2030 and market rankings for key players. Telemedicine transmits biomedical data between patients and caregivers at different locations without face-to-face contact. It saves time and money on healthcare services by providing remote medication, eliminating the need to travel to see a physician. Telemedicine provides expert-based medical care to any place where it is needed without physical contact. It uses existing wired and wireless infrastructures for both prototype and real-time key players in the global telemedicine technologies market are Siemens Healthineers, Koninklijke Philips N.V., Teladoc Health, American Well Corp. (Amwell), Doximity Inc. and SHL Telemedicine. These companies focus on developing telemedicine virtual consultation platforms using hardware, software and Dynamics and Growth FactorsThe global market for telemedicine technologies was valued at $133.7 billion in 2024. The growth rate is attributed to increased virtual consultations between patients and physicians, repetitive virtual consultations for serious illnesses, government investment in digital healthcare and the expansion of telemedicine companies in regions such as North America, Europe and Asia-Pacific. Numerous digital health technologies, such as electronic decision-support tools, telemonitoring, remote monitoring and mobile health applications, are available in developed and emerging countries and are estimated to propel market growth. The increased rate of minimally invasive surgery for patients in Asia-Pacific and European countries, improved virtual consultation technology, increased virtual meetings between patients and physicians, patient convenience and a large geriatric population are several factors driving the global market for telemedicine TechnologiesBeginning in 2024, the healthcare industry has experienced significant transformation driven by advances in telemedicine. Healthcare systems have been upgraded with skilled professionals trained to use new technologies, improving care delivery in emergency rooms and remote locations. The global expansion of clinics and hospitals has further increased the demand for digital tools in healthcare. Concurrently, home care technologies are growing rapidly, fueled by an aging population and rising rates of disability and chronic illness. Moving forward, the focus will shift to software-based devices powered by AI and the Internet of Things (IoT), enabling more personalized, patient-centric care through innovative telemedicine platforms and applications. Report Includes 48 data tables and 75 additional tables Analyses of the trends in the global markets for telemedicine technologies, with revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030 Estimates of the size and revenue prospects for the global market, along with a market share analysis by business offering (components), technology type, application, end user, and region Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, regulations, and the impacts of macroeconomic variables Insights derived from the Porter's Five Forces model, as well as global supply chain analyses An assessment of the telemedicine products and technologies currently available, as well as new developments, spending trends, and growth prospects for this innovation-driven market Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes A review of patent activity and key patent grants Analysis of the industry structure, including companies' product offerings, strategic alliances, M&A activity, venture fundings and investment outlook Profiles of the leading companies, including Siemens Healthineers AG, Koninklijke Philips N.V., Teladoc Health, American Well Corp., and SHL Telemedicine Ltd. Key Attributes: Report Attribute Details No. of Pages 209 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $146.9 Billion Forecasted Market Value (USD) by 2030 $251.5 Billion Compound Annual Growth Rate 11.3% Regions Covered Global Key Topics Covered: Chapter 1 Introduction Market Outlook Scope of the Report Market Summary Market Dynamics and Growth Factors Emerging Technologies Segment Analysis Regional Analysis Conclusion Chapter 2 Market Overview Introduction to Telemedicine Key Communication Technologies and Components of Telemedicine Benefits of Telemedicine Telemedicine Uses and Patient Preferences Macroeconomic Factors Analysis Porter's Five Forces Analysis Bargaining Power of Suppliers Bargaining Power of Buyers Threat of New Entrants Threat of Substitutes Competitive Rivalry/Degree of Competition Chapter 3 Market Dynamics Market Dynamics Key Takeaways Market Drivers Asynchronous Telemedicine Trend Development of the Internet of Things in Telemedicine Telemedicine for Chronic Disease Management Advances in Digital Healthcare Evolving Insurance Sectors Market Restraints Communication Errors Implementation of Telemedicine into Legacy Systems Regulatory Obstacles Market Opportunities Favorable Government Initiatives Acceptance of Telemedicine in Emerging Countries Chapter 4 Regulatory Landscape Regulatory Scenario Legal Aspects of Telemedicine in Various Countries and Their Associated Challenges Chapter 5 Emerging Technologies and Developments Telemedicine Technologies: Overview Telesurgery Telepsychiatry Teleophthalmology Emerging Technologies for Telemedicine Technological Advances in Patient Care Cloud-Based Software Devices Digital Biomarkers Artificial Intelligence in Radiology Internet of Medical Things Patent Analysis Key Findings Chapter 6 Market Segmentation Analysis Segmentation Breakdown Market Analysis by Application Key Takeaways Remote Imaging Telepathology Teledermatology Remote Surgery Telepsychiatry Telecardiology Other Applications Market Analysis by Business Segment Key Takeaways Services Software Hardware Market Analysis by End User Key Takeaways Home Healthcare Healthcare Providers Other End Users Geographic Breakdown Market Analysis by Region Key Takeaways North America Europe Asia-Pacific South America Middle East and Africa Chapter 7 Competitive Intelligence Key Takeaways Competitive Landscape Global Market Shares of Leading Companies Key Developments and Strategies Partnerships and Collaborations Business Expansions Product Launches, Enhancements and Expansions Acquisitions Chapter 8 Sustainability in Telemedicine System: An ESG Perspective Introduction to ESG Implementation of ESG by Healthcare Providers and Payers Key Challenges to Implementing ESG Practices ESG Risk Ratings ESG Practices in the Telemedicine Technologies Industry Environmental Performance Social Performance Governance Performance Concluding Remarks Chapter 9 Appendix Research Methodology References Abbreviations Company Profiles American Well Amc Health Cisco Systems Inc. Cvs Health Doximity Inc. Ge Healthcare Globalmed Holdings Llc. Imedtac Co. Ltd. Koninklijke Philips N.V. Medtronic Siemens Healthnieers Ag Shl Telemedicine Teladoc Health Inc. Telespecialists Tigerconnect For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Global Telemedicine Technologies Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Reuters
2 hours ago
- Business
- Reuters
Siemens Healthineers expects up to $580 million tariff impact in 2026
July 30 (Reuters) - Siemens Healthineers ( opens new tab expects U.S. tariffs to have an impact of up to 500 million euros ($578 million) on 2026 results, its finance chief said on Wednesday, after the European Union and U.S. reached a framework trade agreement on Sunday. The German medical technology company estimates a 400-500 million euro hit in the "most realistic case" for the financial year starting in October, CFO Jochen Schmitz told journalists. He flagged a 200-250 million euro net impact from import duties on the current year. In May, the company had said it expected a 300 million euro hit in the second half of 2025. Its Dutch med-tech peer Philips ( opens new tab also slashed its estimated tariff impact for this year on Tuesday. The EU-U.S. deal sets out a 15% import tariff on most EU goods from next month, lower than the 30% U.S. President Donald Trump had threatened to apply earlier in July. With 10% tariffs having already been in place, Schmitz said Siemens Healthineers took a 100 million euro hit in the third quarter, the results of which it reported on Wednesday. Over the medium term, Schmitz said he believed the company would be able to "manage away" all tariff effects. "That will be a combination partly of pricing, but also value-add structure changes under certain circumstances," he said. However, he added that it was too early to make structural decisions as many aspects of the tariff deal were still unclear. Siemens Healthineers also cited the tariff deal when slightly raising its full-year outlook. It expects annual comparable revenue growth of 5.5% to 6%, after previously guiding for 5-6%, and adjusted basic earnings of 2.30-2.45 euros per share, versus 2.20-2.50 euros expected in May. Its revenue was 5.66 billion euros in the third quarter, slightly above analysts' consensus. The company's shares were up 1.6% in Frankfurt as of 0835 GMT. ($1 = 0.8656 euros)


CNBC
4 hours ago
- Business
- CNBC
'Trade barriers bad for the patients': Siemens Healthineers CEO
Siemens Healthineers CEO Bernd Montag warns EU-U.S. trade barriers are driving up healthcare costs, as company releases its Q2 earnings report.


Reuters
5 hours ago
- Business
- Reuters
Siemens Healthineers meets Q3 sales expectations, raises guidance
July 30 (Reuters) - German medical technology company Siemens Healthineers ( opens new tab on Wednesday reported third-quarter revenue slightly above analysts' consensus, citing strong growth in its China business after declines last year. The company's revenue was 5.66 billion euros ($6.54 billion) in the quarter, compared to the 5.61 billion expected by analysts in a poll compiled by Vara Research and up 7.6% from last year on a comparable basis. Siemens Healthineers also slightly raised its full year outlook, citing the framework trade agreement the European Union and the U.S. reached on Sunday. The company expects comparable revenue growth between 5.5% and 6% in 2025, after previously guiding for 5-6%, and adjusted basic earnings of 2.30-2.45 euros per share, from 2.20-2.50 euros expected in May. "We had a very good quarter with high revenue growth, another increase in profitability and strong free cash flow," CEO Bernd Montag said in a statement, though he added that the geopolitical environment remained highly volatile. The healthcare technology group's free cash flow increased by 54% from the same period last year, reaching 844 million euros in the third quarter that ended on June 30. ($1 = 0.8654 euros)


CNBC
5 hours ago
- Business
- CNBC
European stocks set to open higher as investors digest earnings season
L'Oreal missed second-quarter sales forecasts, posting a 2.4% increase, as growth in Europe slowed more than expected. The cosmetics group saw a small rebound in the U.S. and China, which helped to offset weakness in other regions. However, the company said it will push for exemptions from U.S. tariffs, warning the EU-U.S. trade deal would be costly. — Domi Suskova Siemens Healthineers has topped revenue forecasts for the third quarter, posting 7.6% growth to 5.7 billion euros ($6.6 billion) year on year. The German medical technology group raised the midpoints of its outlook, even as CEO Bernd Montag warned that geopolitical volatility remains high. — Michael Considine Santander posted a record net profit in the second quarter, coming in at 3.4 billion euros ($3.9 billion) and topping expectations. The Spanish lender also unveiled a 1.7 billion euro share buyback program as it reiterated its full year outlook. — Michael Considine Good morning from London. There's just under an hour and a half to go until stocks begin trading, with the futures tied to the Stoxx Europe 600 index pointing to a gain of 0.2% when stock markets open. Regionally, the U.K.'s FTSE 100 and Germany's DAX are expected to rise 0.2% as well. Meanwhile, France CAC 40 index is set to be nearly flat, according to FactSet data. European companies including Santander , BASF , UBS , HSBC , Siemens Healthineers , Mercedes-Benz , L'Oreal and Kering have reported earnings. — Ganesh Rao